Search
Synephrine
go.drugbank.com/drugs/DB09203InvestigationalThe similarity of naming between m-synephrine and the unsubstituted form, synephrine, is a source of some confusion however m-synephrine refers to a related drug more commonly known as phenylephrine.
AT-301
go.drugbank.com/drugs/DB16507InvestigationalAT-301 was under investigation in clinical trial NCT01675284 to evaluate the safety, reactogenicity, and humoral immune responses to an inactivated H5N1 influenza vaccine
KIN-3248
go.drugbank.com/drugs/DB17587Investigational[L45469] In February 2023, Kinnate Biopharma received Fast Track designation from the FDA for KIN-3248 to treat unresectable, locally advanced or metastatic cholangiocarcinoma (CCA).[L45474]
Treamid
go.drugbank.com/drugs/DB16365Investigational, Tolerability and Pharmacokinetics of Treamid in Healthy Volunteers) and NCT04527354 (Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia) by
Green tea leaf
go.drugbank.com/drugs/DB14307InvestigationalGreen tea leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Mixtures: GONGFUTOUTANG Tou Tang Powder No. 3Ertiprotafib
go.drugbank.com/drugs/DB06521ExperimentalErtiprotafib belongs to a novel class of insulin sensitizers developed for treatment of type 2 diabetes. In insulin-resistant rodent models, ertiprotafib and a close analog lowered both fasting blood glucose and insulin levels and improv...
Troxacitabine
go.drugbank.com/drugs/DB04961InvestigationalTroxacitabine is a nucleoside analog with antineoplastic activity. There has been growing interest in its development for the treatment of patients with refractory lymphoproliferative conditions.
Quinfamide
go.drugbank.com/drugs/DB12780InvestigationalQuinfamide has been used in trials studying the treatment of Amoebiasis and Helminthiasis.
Mixtures: LOXCELL NFPhenserine
go.drugbank.com/drugs/DB04892InvestigationalPhenserine is under development by Axonyx, a US biopharmaceutical company that focuses on treatments for dementia.